Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, Mexico.
J Neuroendocrinol. 2020 Nov;32(11):e12858. doi: 10.1111/jne.12858. Epub 2020 May 25.
The hormone prolactin (PRL) is emerging as an important regulator of ocular blood vessels. PRL is pro-angiogenic and acquires anti-angiogenic properties after undergoing proteolytic cleavage to the PRL fragment, vasoinhibin. The vascularisation of the rodent retina develops after birth when it rapidly expands until completion at the end of the first postnatal week. Exposure of newborn mice to high oxygen levels lowers the rate of blood vessel growth. In the present study, we investigated whether PRL treatment modifies the vascularisation of the retina in newborn mice exposed to high oxygen or to normoxia and whether the retinal conversion of PRL to vasoinhibin may be altered in the neonate. Newborn mice and their nursing mothers were subjected to 75% oxygen or to normoxia from postnatal day (P) 6 to P8 (group 1) or from P2 to P5 (group 2). PRL (2 µg g , i.p., twice a day) or vehicle was injected from P5 to P8 in group 1 and from P1 to P5 in group 2. PRL treatment reduced the retinal inhibition of blood vessel growth and the increase in vascular regression induced by hyperoxia as revealed by immunofluorescence staining of blood vessels and the expression of angiogenesis and apoptosis markers. The pro-angiogenic effect may involve a reduced conversion of PRL to vasoinhibin. Incubation of PRL with retinal extracts showed reduced activity of the PRL-cleaving protease, cathepsin D, in the neonate vs the adult retina that was further reduced under hyperoxia. PRL and the PRL receptor mRNA were expressed at higher levels in the retina at P8 than in the adult, whereas endogenous PRL was undetectable in the circulation at P8. We conclude that PRL has a pro-angiogenic effect in the neonate retina as a result of its reduced conversion to vasoinhibin and that PRL produced by the retina may help promote physiological vascularisation after birth.
催乳素(PRL)作为一种重要的眼部血管调节激素正在逐渐被认识。PRL 具有促血管生成作用,经蛋白水解酶切割为 PRL 片段(血管抑制素)后获得抗血管生成特性。啮齿动物视网膜的血管化发生于出生后,此时其迅速扩张,直到出生后第一周结束时完成扩张。将新生小鼠暴露于高氧环境中会降低血管生长速度。在本研究中,我们探讨了 PRL 处理是否会改变新生小鼠在高氧或常氧环境下视网膜的血管生成情况,以及 PRL 向血管抑制素转化是否会在新生儿中发生改变。新生小鼠及其哺乳期母鼠从出生后第 6 天(P6)至 P8 天(第 1 组)或从 P2 天至 P5 天(第 2 组)接受 75%的氧气或常氧。第 1 组从 P5 天至 P8 天,第 2 组从 P1 天至 P5 天,每天腹腔注射 2μg PRL(2 次)或载体。PRL 处理可减少视网膜血管生长抑制和血管退化增加,这一作用通过血管免疫荧光染色和血管生成及凋亡标志物的表达得到证实。促血管生成作用可能涉及 PRL 向血管抑制素转化减少。PRL 与视网膜提取物孵育显示,新生鼠的 PRL 切割蛋白酶,组织蛋白酶 D 的活性降低,而在高氧环境下进一步降低。与成年鼠相比,PRL 和 PRL 受体 mRNA 在 P8 时在视网膜中表达水平更高,而 P8 时循环中的内源性 PRL 无法检测到。综上,PRL 在新生鼠视网膜中具有促血管生成作用,是由于其向血管抑制素转化减少,而视网膜产生的 PRL 可能有助于促进出生后的生理性血管生成。